<p>SANUWAVE Health（納斯達克代碼：SNWV - 獲取免費報告）在週三發佈給投資者的報告中，被 Northland Capmk 的投資分析師上調至 “強力買入” 評級，Zacks.com 報道。</p>
<p>其他一些券商也對 SNWV 發表了看法。Northland Securities 在週三的一份研究報告中開始覆蓋 SANUWAVE Health。他們對該股票設定了 “跑贏大盤” 的評級和 55.00 美元的目標價。Wall Street Zen 在 8 月 30 日（星期六）的一份研究報告中將 SANUWAVE Health 的評級從 “買入” 上調至 “強力買入”。最後，Roth Capital 在 8 月 22 日（星期五）的一份研究報告中將 SANUWAVE Health 的目標價從 54.00 美元上調至 55.00 美元，並給予該公司 “買入” 評級。一位研究分析師給予該股票 “強力買入” 評級，另外兩位給予 “買入” 評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “買入”，平均目標價為 55.00 美元。</p>
<p>獲取 <strong>SANUWAVE Health</strong> 警報：</p>
<p><strong>查看我們關於 SNWV 的最新研究報告</strong></p>
<h2>SANUWAVE Health 價格表現</h2>
<p>SANUWAVE Health 的股票在週三開盤價為 38.81 美元。SANUWAVE Health 的 52 周低點為 5.21 美元，52 周高點為 46.58 美元。該公司的市值為 3.326 億美金，市盈率為-4.70，貝塔值為 1.39。該股票的 50 日簡單移動平均線為 37.20 美元。</p>
<p>SANUWAVE Health（納斯達克代碼：SNWV - 獲取免費報告）最近在 8 月 8 日（星期五）發佈了季度財報。該公司報告季度每股收益為 0.01 美元，超出分析師共識預期的-0.09 美元 0.10 美元。該業務的季度收入為 1016 萬美元，而分析師預期為 1014 萬美元。SANUWAVE Health 已將其 2025 年第三季度的指引設定為每股收益。2025 財年的指引為每股收益。</p>
<h2>機構投資者對 SANUWAVE Health 的看法</h2>
<p>對該公司的對沖基金和其他機構投資者最近調整了持股。Solas Capital Management LLC 在第一季度購買了價值約 20658000 美元的 SANUWAVE Health 新股份。Strategic Investment Solutions Inc. IL 在第一季度購買了價值約 47000 美元的 SANUWAVE Health 新股份。AWM Investment Company Inc.在第一季度購買了價值約 18153000 美元的 SANUWAVE Health 新股份。Rhumbline Advisers 在第二季度購買了價值約 211000 美元的 SANUWAVE Health 新股份。最後，MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第二季度購買了價值約 126000 美元的 SANUWAVE Health 新股份。機構投資者持有該公司 42.53% 的股票。</p>
<h2>關於 SANUWAVE Health</h2>
<p>（獲取免費報告）</p>
<p>SANUWAVE Health, Inc 是一家衝擊波技術公司，研究、開發並商業化非侵入性、高能量和聲學衝擊波，用於再生醫學及其他應用，覆蓋美國及國際市場。其衝擊波用於產生生物反應，使身體通過修復和再生組織以及肌肉骨骼和血管結構自我癒合。</p>
<h2>瞭解更多</h2>
<ul>
<li>我們更看好的五隻股票，勝過 SANUWAVE Health</li>
<li>即將到來的 IPO 股票鎖定期，解釋</li>
<li>開學購物達到 400 億美元：現在值得關注的三隻零售股票</li>
<li>恒生指數是什麼？</li>
<li>Alphabet 股票在躲避嚴厲的反壟斷措施後飆升</li>
<li>保護您的投資組合免受冠狀病毒傳播的三隻股票</li>
<li>為什麼高通在經歷數月滯後後表現優於 NVIDIA</li>
</ul>
<p><em>此即時新聞警報由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 SANUWAVE Health 嗎？</h2>
<p>在考慮 SANUWAVE Health 之前，你會想聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買...而 SANUWAVE Health 並不在名單上。</p>
<p>雖然 SANUWAVE Health 目前在分析師中獲得 “買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

SNWV

<p>Northland Capital Markets 將 SANUWAVE Health (NASDAQ:SNWV) 的評級上調至 “強力買入”。其他券商也對該股票給予了積極評價，普遍評級為 “買入”，平均目標價為 55.00 美元。SANUWAVE Health 的股票開盤價為 38.81 美元，52 周區間為 5.21 至 46.58 美元。該公司報告的季度每股收益為 0.01 美元，超出預期。機構投資者持有該股票的 42.53%，顯示出對公司的強烈興趣</p>

<p>Sanuwave Health (NASDAQ:SNWV - Get Free Report) was upgraded by investment analysts at Northland Capmk to a &#34;strong-buy&#34; rating in a note issued to investors on Wednesday,Zacks.com reports.</p>
<div class="lb-trans"><p>SANUWAVE Health（納斯達克代碼：SNWV - 獲取免費報告）在週三發佈給投資者的報告中，被 Northland Capmk 的投資分析師上調至 “強力買入” 評級，Zacks.com 報道。</p>
</div><p>A number of other brokerages have also weighed in on SNWV. Northland Securities started coverage on Sanuwave Health in a research report on Wednesday. They set an &#34;outperform&#34; rating and a $55.00 price objective on the stock. Wall Street Zen raised Sanuwave Health from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a research note on Saturday, August 30th. Finally, Roth Capital boosted their price objective on Sanuwave Health from $54.00 to $55.00 and gave the company a &#34;buy&#34; rating in a research note on Friday, August 22nd. One research analyst has rated the stock with a Strong Buy rating and two have given a Buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of &#34;Buy&#34; and an average price target of $55.00.</p>
<div class="lb-trans"><p>其他一些券商也對 SNWV 發表了看法。Northland Securities 在週三的一份研究報告中開始覆蓋 SANUWAVE Health。他們對該股票設定了 “跑贏大盤” 的評級和 55.00 美元的目標價。Wall Street Zen 在 8 月 30 日（星期六）的一份研究報告中將 SANUWAVE Health 的評級從 “買入” 上調至 “強力買入”。最後，Roth Capital 在 8 月 22 日（星期五）的一份研究報告中將 SANUWAVE Health 的目標價從 54.00 美元上調至 55.00 美元，並給予該公司 “買入” 評級。一位研究分析師給予該股票 “強力買入” 評級，另外兩位給予 “買入” 評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “買入”，平均目標價為 55.00 美元。</p>
</div><p>Get <strong>Sanuwave Health</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>SANUWAVE Health</strong> 警報：</p>
</div><p><strong>View Our Latest Research Report on SNWV</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 SNWV 的最新研究報告</strong></p>
</div><h2>Sanuwave Health Price Performance</h2>
<div class="lb-trans"><h2>SANUWAVE Health 價格表現</h2>
</div><p>Sanuwave Health stock opened at $38.81 on Wednesday. Sanuwave Health has a 52 week low of $5.21 and a 52 week high of $46.58. The firm has a market cap of $332.60 million, a PE ratio of -4.70 and a beta of 1.39. The stock's fifty day simple moving average is $37.20.</p>
<div class="lb-trans"><p>SANUWAVE Health 的股票在週三開盤價為 38.81 美元。SANUWAVE Health 的 52 周低點為 5.21 美元，52 周高點為 46.58 美元。該公司的市值為 3.326 億美金，市盈率為-4.70，貝塔值為 1.39。該股票的 50 日簡單移動平均線為 37.20 美元。</p>
</div><p>Sanuwave Health (NASDAQ:SNWV - Get Free Report) last posted its quarterly earnings results on Friday, August 8th. The company reported $0.01 EPS for the quarter, topping analysts' consensus estimates of ($0.09) by $0.10. The business had revenue of $10.16 million for the quarter, compared to analyst estimates of $10.14 million. Sanuwave Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS.</p>
<div class="lb-trans"><p>SANUWAVE Health（納斯達克代碼：SNWV - 獲取免費報告）最近在 8 月 8 日（星期五）發佈了季度財報。該公司報告季度每股收益為 0.01 美元，超出分析師共識預期的-0.09 美元 0.10 美元。該業務的季度收入為 1016 萬美元，而分析師預期為 1014 萬美元。SANUWAVE Health 已將其 2025 年第三季度的指引設定為每股收益。2025 財年的指引為每股收益。</p>
</div><h2>Institutional Investors Weigh In On Sanuwave Health</h2>
<div class="lb-trans"><h2>機構投資者對 SANUWAVE Health 的看法</h2>
</div><p>Hedge funds and other institutional investors have recently modified their holdings of the company. Solas Capital Management LLC bought a new stake in shares of Sanuwave Health during the first quarter valued at approximately $20,658,000. Strategic Investment Solutions Inc. IL bought a new stake in shares of Sanuwave Health during the first quarter valued at approximately $47,000. AWM Investment Company Inc. bought a new stake in shares of Sanuwave Health during the first quarter valued at approximately $18,153,000. Rhumbline Advisers bought a new stake in shares of Sanuwave Health during the second quarter valued at approximately $211,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Sanuwave Health during the second quarter valued at approximately $126,000. Institutional investors own 42.53% of the company's stock.</p>
<div class="lb-trans"><p>對該公司的對沖基金和其他機構投資者最近調整了持股。Solas Capital Management LLC 在第一季度購買了價值約 20658000 美元的 SANUWAVE Health 新股份。Strategic Investment Solutions Inc. IL 在第一季度購買了價值約 47000 美元的 SANUWAVE Health 新股份。AWM Investment Company Inc.在第一季度購買了價值約 18153000 美元的 SANUWAVE Health 新股份。Rhumbline Advisers 在第二季度購買了價值約 211000 美元的 SANUWAVE Health 新股份。最後，MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第二季度購買了價值約 126000 美元的 SANUWAVE Health 新股份。機構投資者持有該公司 42.53% 的股票。</p>
</div><h2>About Sanuwave Health</h2>
<div class="lb-trans"><h2>關於 SANUWAVE Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.</p>
<div class="lb-trans"><p>SANUWAVE Health, Inc 是一家衝擊波技術公司，研究、開發並商業化非侵入性、高能量和聲學衝擊波，用於再生醫學及其他應用，覆蓋美國及國際市場。其衝擊波用於產生生物反應，使身體通過修復和再生組織以及肌肉骨骼和血管結構自我癒合。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Sanuwave Health</li>
<li>Upcoming IPO Stock Lockup Period, Explained</li>
<li>Back-to-School Shopping Hits $40B: 3 Retail Stocks to Watch Now</li>
<li>What is the Hang Seng index?</li>
<li>Alphabet Stock Surges After Dodging Harsh Antitrust Remedies</li>
<li>3 Stocks to Protect Your Portfolio from the Coronavirus Contagion</li>
<li>Why Qualcomm Is Outperforming NVIDIA After Months of Lagging</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，勝過 SANUWAVE Health</li>
<li>即將到來的 IPO 股票鎖定期，解釋</li>
<li>開學購物達到 400 億美元：現在值得關注的三隻零售股票</li>
<li>恒生指數是什麼？</li>
<li>Alphabet 股票在躲避嚴厲的反壟斷措施後飆升</li>
<li>保護您的投資組合免受冠狀病毒傳播的三隻股票</li>
<li>為什麼高通在經歷數月滯後後表現優於 NVIDIA</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞警報由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Sanuwave Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 SANUWAVE Health 嗎？</h2>
</div><p>Before you consider Sanuwave Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 SANUWAVE Health 之前，你會想聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sanuwave Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買...而 SANUWAVE Health 並不在名單上。</p>
</div><p>While Sanuwave Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 SANUWAVE Health 目前在分析師中獲得 “買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

SANUWAVE Health（NASDAQ:SNWV）在 Northland Capmk 被升級為 “強力買入” 評級